Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation

Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin P. Rosenheck, Kashika Goyal, Tara Fallah, Pamela Burcham, Kukbin Choi, Matthew Henn, Elie Homsy, Scott Visovatti, Veronica Franco
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JHLT Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000084
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087412244742144
author Justin P. Rosenheck
Kashika Goyal
Tara Fallah
Pamela Burcham
Kukbin Choi
Matthew Henn
Elie Homsy
Scott Visovatti
Veronica Franco
author_facet Justin P. Rosenheck
Kashika Goyal
Tara Fallah
Pamela Burcham
Kukbin Choi
Matthew Henn
Elie Homsy
Scott Visovatti
Veronica Franco
author_sort Justin P. Rosenheck
collection DOAJ
description Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia and erythrocytosis which can impact outcomes of lung transplantation. This is the first described case of a patient undergoing lung transplantation while receiving sotatercept for PAH.
format Article
id doaj-art-b01338c2f11843fcad28a0ae4a334ffd
institution Kabale University
issn 2950-1334
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series JHLT Open
spelling doaj-art-b01338c2f11843fcad28a0ae4a334ffd2025-02-06T05:13:09ZengElsevierJHLT Open2950-13342025-05-018100213Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung TransplantationJustin P. Rosenheck0Kashika Goyal1Tara Fallah2Pamela Burcham3Kukbin Choi4Matthew Henn5Elie Homsy6Scott Visovatti7Veronica Franco8Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH; Reprint requests: Justin P. Rosenheck, Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, 241 W. 11th Avenue, 5th Floor, Suite 5055L, Columbus, OH 43201.Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHOhio State University, College of Pharmacy, 217 Lloyd M. Parks Hall, 500 West 12th Ave, Columbus OH 43210Ohio State University, College of Pharmacy, 217 Lloyd M. Parks Hall, 500 West 12th Ave, Columbus OH 43210Ohio State University, Department of Surgery, Division of Cardiac Surgery, 410 W. 10th Ave, Columbus OH 43210Ohio State University, Department of Surgery, Division of Cardiac Surgery, 410 W. 10th Ave, Columbus OH 43210Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHOhio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 452 W 10th Ave, Columbus, OH 43210Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 452 W 10th Ave, Columbus, OH 43210Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia and erythrocytosis which can impact outcomes of lung transplantation. This is the first described case of a patient undergoing lung transplantation while receiving sotatercept for PAH.http://www.sciencedirect.com/science/article/pii/S2950133425000084Pulmonary Arterial HypertensionPAHGroup 1Lung TransplantSotatercept
spellingShingle Justin P. Rosenheck
Kashika Goyal
Tara Fallah
Pamela Burcham
Kukbin Choi
Matthew Henn
Elie Homsy
Scott Visovatti
Veronica Franco
Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
JHLT Open
Pulmonary Arterial Hypertension
PAH
Group 1
Lung Transplant
Sotatercept
title Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
title_full Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
title_fullStr Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
title_full_unstemmed Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
title_short Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
title_sort sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation
topic Pulmonary Arterial Hypertension
PAH
Group 1
Lung Transplant
Sotatercept
url http://www.sciencedirect.com/science/article/pii/S2950133425000084
work_keys_str_mv AT justinprosenheck sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT kashikagoyal sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT tarafallah sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT pamelaburcham sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT kukbinchoi sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT matthewhenn sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT eliehomsy sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT scottvisovatti sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation
AT veronicafranco sotaterceptuseinapatientwithpulmonaryarterialhypertensionundergoinglungtransplantation